PLANETS
27.1.2023 18:01:35 CET | Business Wire | Press release
Approximately 100,000 people from overseas visited teamLab Planets in Toyosu, Tokyo, between December 9, 2022 and January 9, 2023. (*1)
Of the visitors across one month, around 60% , or 1 in 2 visitors, were non-residents visiting Japan (*1), and the number of visitors from overseas has tripled compared to the same month in 2019 (before COVID-19).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230126005440/en/
teamLab, Floating in the Falling Universe of Flowers © teamLab
Furthermore, according to a survey conducted by the museum, about 70% of the visitors from overseas knew about the museum before considering their trip to Japan, and there was a trend of the museum being one of the main purposes to visit Tokyo. (*2)
*1 From the official website tickets purchaser data (survey period: December 9, 2022 - January 9, 2023)
*2 From the visitor survey data (survey period: December 17, 2022 - January 10, 2023)
We will continue to provide people around the world an experience based on teamLab Planets’ concept, “Immerse your Body, and with Others, Become One with the World”.
From Wednesday, March 1, 2023 to Sunday, April 30, 2023, two works, Floating in the Falling Universe of Flowers and Drawing on the Water Surface Created by the Dance of Koi and People - Infinity, will feature cherry blossoms that bloom across the space, on view during the spring season only.
Floating in the Falling Universe of Flowers, an artwork in which flowers bloom and change with the passage of time, and the universe of life spreads across the space, will be filled with cherry blossoms during this limited period. In the work Drawing on the Water Surface Created by the Dance of Koi and People - Infinity, visitors walk in water and koi swim on the surface of the infinitely expanding water. When the koi collide with people, they turn into cherry blossoms and scatter.
[Works that will feature cherry blossoms]
Floating in the Falling Universe of Flowers
teamLab, 2016-2018, Interactive Digital Installation, Endless, Sound: Hideaki Takahashi
Artwork: https://planets.teamlab.art/tokyo/ew/fitfuof/
Video: https://youtu.be/FzJ5svgIueQ
A seasonal year of flowers bloom and change with time, life spreads out into the universe.
Lie down or sit still in the space and eventually your body floats and you dissolve into the artwork.
Flowers grow, bud, bloom, and in time, the petals fall, and the flowers wither and die. The cycle of birth and death continues for perpetuity.
The artwork is not a pre-recorded image that is played back; it is created by a computer program that continuously renders the artwork in real time. As a whole, it is continuously changing, and previous visual states are never replicated. The universe at this moment in time can never be seen again.
Drawing on the Water Surface Created by the Dance of Koi and People - Infinity
teamLab, 2016-2018, Interactive Digital Installation, Endless, Sound: Hideaki Takahashi
Artwork: https://planets.teamlab.art/tokyo/ew/koi_and_people/
Video: https://youtu.be/SsRNptTOniw
Koi swim on the surface of water that stretches out into infinity. People can walk into the water.
The movement of the koi is influenced by the presence of people in the water and also other koi. When the fish collide with people they turn into flowers and scatter. Throughout the year, the flowers that bloom will change along with the seasons.
The trajectory of the koi is determined by the presence of people and these trajectories trace lines on the surface of the water.
The work is rendered in real time by a computer program. It is neither prerecorded nor on loop. The interaction between the viewer and the installation causes continuous change in the artwork. Previous visual states can never be replicated, and will never reoccur.
[Enjoy vegan ramen in an art space]
Vegan Ramen UZU Tokyo, a vegan ramen restaurant from Kyoto, opened in October 2021 on the same premises as teamLab Planets. Diners can enjoy ramen in teamLab’s Reversible Rotation - Non-Objective Space artwork space, as well as the Table of Sky and Fire and One Stroke Bench outside of the restaurant. Vegan Ramen UZU Tokyo also has vegan ice cream and various teas that are only available in Tokyo. The restaurant can be visited without entry to teamLab Planets.
Vegan Ramen UZU Tokyo: https://vegan-uzu.com/pages/uzu-tokyo
[teamLab Planets TOKYO]
teamLab, Floating Flower Garden; Flowers and I are of the Same Root, the Garden and I are One © teamLab
teamLab Planets is a museum where you walk through water, and a garden where you become one with the flowers. There are four massive exhibition spaces and two gardens.
By immersing your entire body with other people in these massive artworks, the boundary between the body and the artwork dissolves. The self, others, and the world become continuous, and we explore a new relationship without boundaries between ourselves and the world.
Enter barefoot, immerse your body with others in the artwork spaces, and become one with the world.
[Exhibition details]
teamLab Planets TOKYO
Location: teamLab Planets TOKYO, 6-1-16 Toyosu, Koto-ku, Tokyo
[Opening hours]
January - April
Monday - Friday 10:00 - 20:00
Saturdays, Sundays, and holidays 9:00 - 21:00
*March 20 (Mon), March 22 (Wed) - March 24 (Fri) 9:00 - 21:00
*March 25 (Sat) - April 2 (Sun) 9:00 - 22:00
*April 29 (Sat), April 30 (Sun) 9:00 - 22:00
*Last entry 1 hour before closing
[Closed]
February 9 (Thu), March 2 (Thu), April 13 (Thu)
*Opening hours are subject to change. Please check the official website for the latest details.
Official website: https://planets.teamlab.art/tokyo/
teamLab Planets Highlight Video: https://youtu.be/oiQoe9Ow9o0
*teamLab Planets will be open in Toyosu, Tokyo until the end of 2023.
[Tickets]
Adult: 3,200 JPY
Junior high and high school students: 2,000 JPY
Children (4 to 12 years old): 1,000 JPY
3 years old and under: Free
Disability discount: 1,600 JPY
*From Saturday, April 1, 2023: ticket prices for weekends, public holidays, and dates with extended opening hours will change to the prices below.
Adult: 3,500 JPY
Junior high and high school students: 2,300 JPY
Children (4 to 12 years old): 1,300 JPY
3 years old and under: Free
Disability discount: 1,900 JPY
teamLab Planets TOKYO DMM Ticket Store: https://teamlabplanets.dmm.com
[Measures to prevent the spread of COVID-19]
Please check the link below for details on the infection prevention measures implemented at teamLab Planets: https://teamlabplanets.dmm.com/covid-19
[Official HP/Social Media]
Official website: https://planets.teamlab.art/tokyo/
Instagram: https://www.instagram.com/teamlab.planets/
Facebook: https://www.facebook.com/TL.Planets/
Twitter: https://twitter.com/teamLabPlanets
#teamLabPlanets
[Food & Shop]
Vegan Ramen UZU Tokyo: https://vegan-uzu.com/pages/uzu-tokyo
teamLab Flower Shop & Art
*Please check the official website for opening hours
*Closed on the same days as teamLab Planets
[Measures to prevent the spread of COVID-19 (applicable to Food & Shop)]
・Implementation of regular cleaning and disinfection
・Seat disinfection after each customer
・Hand disinfection upon entry
・Restrictions on the number of people in the space
・Ensuring sufficient space between seats
・Employees wear masks
・Removal of tabletop items
・Temperature measurement
[Press kit]
https://goo.gl/tQXMLm
[PLANETS Co., Ltd.]
Established in 2017. Operates and manages the facilities of teamLab Planets TOKYO.
Location: Tokyo Nihonbashi Tower 10F, 2-7-1 Nihonbashi, Chuo-ku, Tokyo
Representative: Takumi Nomoto
[teamLab]
teamLab (f. 2001) is an international art collective. Their collaborative practice seeks to navigate the confluence of art, science, technology, and the natural world. Through art, the interdisciplinary group of specialists, including artists, programmers, engineers, CG animators, mathematicians, and architects, aims to explore the relationship between the self and the world, and new forms of perception.
In order to understand the world around them, people separate it into independent entities with perceived boundaries between them. teamLab seeks to transcend these boundaries in our perceptions of the world, of the relationship between the self and the world, and of the continuity of time. Everything exists in a long, fragile yet miraculous, borderless continuity.
teamLab exhibitions have been held in cities worldwide, including New York, London, Paris, Singapore, Silicon Valley, Beijing, and Melbourne among others. teamLab museums and large-scale permanent exhibitions include teamLab Borderless and teamLab Planets in Tokyo, teamLab Borderless Shanghai, teamLab SuperNature Macao, and teamLab Massless Beijing, with more to open in cities including Abu Dhabi, Hamburg, Jeddah, and Utrecht.
teamLab’s works are in the permanent collection of the Museum of Contemporary Art, Los Angeles; Art Gallery of New South Wales, Sydney; Art Gallery of South Australia, Adelaide; Asian Art Museum, San Francisco; Asia Society Museum, New York; Borusan Contemporary Art Collection, Istanbul; National Gallery of Victoria, Melbourne; and Amos Rex, Helsinki.
Website: https://www.teamlab.art/
Instagram: https://instagram.com/teamlab/
Facebook: https://www.facebook.com/teamLab.inc
Twitter: https://twitter.com/teamLab_net
YouTube: https://www.youtube.com/c/teamLabART
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230126005440/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release
Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release
About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,
AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release
Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break
Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release
Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti
Axway Positioned as a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment27.3.2026 18:46:00 CET | Press release
Axway, a 74Software company (Euronext: 74SW) and global leader in federated API management and enterprise integration, has been named a Leader in the IDC MarketScape: Worldwide API Management 2026 Vendor Assessment.1 Axway Amplify securely connects, orchestrates, and automates data integration. Organizations in financial services, manufacturing, healthcare, and other industries rely on Amplify to modernize integrations and confidently unlock data to deliver superior digital services faster. The report notes: “The platform benefits from Axway’s long-standing experience in B2B integration, secure file transfer, and legacy connectivity, providing differentiated capabilities for organizations that need to expose and control APIs around core systems that are not cloud-native.”1 This multi-pattern expertise in security, integration, and federated governance — built during the early phases of the API-driven digital transformation — becomes especially critical as enterprises seek to govern dat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom